Replies to post #428442 on NorthWest Biotherapeutics Inc (NWBO)

[MI Dendream]

They gave you the numbers already. They can treat 4-6 patients from London and 45-50 patients per month from Sawston. They are charging £150k for the full set of therapy. My understanding is that you don’t need to be British to be special so long as their is capacity. A real shame for those well insured Americans who work so hard but cannot spend over $500k all-in when they are dying and their family needs that money.

This is not going to be the global price, but it may be UK pricing going forward. That means most companies would go for about £225k in the biggest market and just shy of that in the second biggest market of people from multinational locations speaking variations of the same tongue. Followed by their Viking brethren at slightly lower pricing once again Australia and Isreal will come to the table with cash and through distributors so will their neighbors. Czechs will pay less than British and Greeks and the other teetering European markets will pay even less.

[MI Dendream]

And BTW US Hospitals will charge close to three times that to net at least 50% over cost. Insurance plans will cry and raise premiums accordingly. They and PBMs will split the new profits unless NWBO goes single channel controlled distribution and squeezes PBM out…medical benefit?

Drug company will give away free and discounted drug where necessary and allowed by state and federal law. Meaning, sorry American Scandinavians & Mung people, elderly with gaps in coverage, certain New Englanders, and a few more. Some money will be available through charitable contributions for those people.